IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 1 holdings | $6.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pliant Therapeutics, Inc.(PLRX)COM729139105$6.1M339,160100.0%